Concordiarx
Concordia develops and commercializes pharmaceutical products for the treatment of attention deficit hyperactivity disorder, cancer and asthma.
Business Model:
Revenue: $569.6M
Employees: 201-500
Rankings
Detailed Concordiarx Information
Concordiarx was acquired by
AMCo.
The acquisition happend on 2014-10-02.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 277 Lakeshore Road East
City: Oakville
State: ontario
Zip: L6J 1H9
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Concordia develops and commercializes pharmaceutical products for the treatment of attention deficit hyperactivity disorder, cancer and asthma.
Contact Phone:
+19058425150
Contact Email:
Concordiarx went public on the FRA
Listed Exchange:
FRA
Ticker Symbol:
CXR
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
